Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04313881 |
|---|---|
| Brief Title: | Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS) (ENHANCE) |
| First Submitted : | March 11, 2020 |
| First Submitted that Met QC Criteria : | March 17, 2020 |
| First Posted : | March 18, 2020 |
| Last Update Submitted that Met QC Criteria : | June 8, 2023 |
| Last Update Posted : | June 9, 2023 (Estimate) |